Xeljanz Clinical Trials
Here are the 6 most popular medical studies for xeljanz
Monoclonal Antibodies
Vedolizumab + Tofacitinib for Ulcerative Colitis
Recruiting3 awardsPhase 4
Los Angeles, California
This trial will test the effectiveness of vedolizumab+tofacitinib and vedolizumab alone in treating adults with moderate-severe UC. Participants will receive vedolizumab+tofacitinib for 8 weeks and then be monitored for response. Those who show response will receive vedolizumab alone for 44 weeks.
Benzodiazepine
Multiple Therapies for Down Syndrome Regression Disorder
Recruiting1 awardPhase 2
Los Angeles, California
This trial looks at treatments for Down Syndrome Regression Disorder, a condition seen in adolescents and young adults with Down Syndrome that can cause hallucinations, delusions, aggression, and difficulty with daily activities.
Popular filter options for xeljanz trials
Clinical Trials With No Placebo
View 17 medical studies that do not have a placebo group.
Janus Kinase (JAK) Inhibitor
Oral Tofacitinib for Ulcerative Colitis in Children
Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial is designed to see if tofacitinib is effective in treating pediatric UC patients who have either failed or been intolerant to other treatments. The primary objective is to see if the patients go into remission after 44 weeks of treatment.
Small Molecule
Tofacitinib for Uveitis
Recruiting3 awardsPhase 2
Saint Louis, Missouri
Non-infectious inflammatory eye disease, such as uveitis and scleritis, is a chronic, auto-immune process that leads to vision loss. While steroids are effective in the short term, the side-effect profile of chronic steroid use necessitates the identification of effective steroid-sparing therapies. Tofacitinib is a small molecule that inhibits the signaling pathways of multiple inflammatory cytokines. The investigators plan to evaluate whether tofacitinib may have efficacy for patients with uveitis and / or scleritis.
View More Xeljanz Trials
See another 2 medical studies focused on xeljanz.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.